Citation: Bm. Lomaestro et Ma. Piatek, UPDATE ON DRUG-INTERACTIONS WITH AZOLE ANTIFUNGAL AGENTS, The Annals of pharmacotherapy, 32(9), 1998, pp. 915-928
Citation: Ts. Lesar et al., MEDICATION-PRESCRIBING ERRORS IN A TEACHING HOSPITAL - A 9-YEAR EXPERIENCE, Archives of internal medicine, 157(14), 1997, pp. 1569-1576
Citation: Mw. Griswold et al., QUINUPRISTIN-DALFOPRISTIN (RP-59500) - AN INJECTABLE STREPTOGRAMIN COMBINATION, American journal of health-system pharmacy, 53(17), 1996, pp. 2045-2053
Citation: Sl. Preston et al., DOSING ADJUSTMENT OF 10 ANTIMICROBIALS FOR PATIENTS WITH RENAL IMPAIRMENT, The Annals of pharmacotherapy, 29(12), 1995, pp. 1202-1207
Citation: Bm. Lomaestro et M. Malone, GLUTATHIONE IN HEALTH AND DISEASE - PHARMACOTHERAPEUTIC ISSUES, The Annals of pharmacotherapy, 29(12), 1995, pp. 1263-1273
Citation: Bm. Lomaestro et Ts. Lesar, CONTINUING PROBLEM OF CIPROFLOXACIN ADMINISTERED WITH INTERACTING DRUGS, American journal of hospital pharmacy, 51(6), 1994, pp. 832-832
Citation: Bm. Lomaestro et Gr. Bailie, EFFECT OF MULTIPLE STAGGERED DOSES OF CALCIUM ON THE BIOAVAILABILITY OF CIPROFLOXACIN, The Annals of pharmacotherapy, 27(11), 1993, pp. 1325-1328